Sylebra Capital (HK) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PureCycle Technologies
PCT
|
+$504M |
| 2 |
AEVA
Aeva Technologies
AEVA
|
+$289M |
| 3 |
YSG
Yatsen Holding
YSG
|
+$70.6M |
| 4 |
Elastic
ESTC
|
+$48.8M |
| 5 |
Opendoor
OPEN
|
+$37.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enphase Energy
ENPH
|
+$212M |
| 2 |
Chegg
CHGG
|
+$106M |
| 3 |
PagSeguro Digital
PAGS
|
+$87.6M |
| 4 |
Futu Holdings
FUTU
|
+$70.6M |
| 5 |
NOVA
Sunnova Energy
NOVA
|
+$47.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 73.22% |
| 2 | Industrials | 11.32% |
| 3 | Consumer Staples | 6.14% |
| 4 | Consumer Discretionary | 3.31% |
| 5 | Financials | 3.14% |
Similar funds
Sylebra Capital (HK)'s Q1 2021 Portfolio in Review
As of Q1 2021, Sylebra Capital (HK) held 31 positions worth $3.87B, down 1.7% from $3.94B the previous quarter. Its ten largest holdings account for 82% of the portfolio.
Sylebra Capital (HK) deployed $397M of net new capital in Q1 2021, opening 5 new positions and adding to 10 existing holdings. Its largest new stake was PureCycle Technologies: 17,182,391 shares worth $438M.
By sector, the portfolio is most concentrated in Technology at 73% of assets, down from 85% a quarter earlier, followed by Industrials and Consumer Staples.
On the sell side, the largest reduction was Enphase Energy, an estimated $212M trimmed.
- Sylebra Capital (HK)'s largest Q1 2021 buy was PureCycle Technologies: 17,182,391 shares worth $438M.
- Sylebra Capital (HK) added most to Aeva Technologies in Q1 2021, an estimated $289M increase.
- Sylebra Capital (HK)'s biggest Q1 2021 reduction was Enphase Energy, cutting an estimated $212M.
- Sylebra Capital (HK) fully exited Repay Holdings in Q1 2021, selling an estimated $21.7M.
- Sylebra Capital (HK)'s ten largest holdings make up 82% of its $3.87B portfolio in Q1 2021.
- Sylebra Capital (HK) opened 5 new positions and closed 6 in Q1 2021.
- Sylebra Capital (HK)'s portfolio value fell 1.7% quarter-over-quarter to $3.87B.
Based on Sylebra Capital (HK)'s 13F filing for Q1 2021, filed 18 May 2021.